Conduit Pharmaceuticals Inc (CDT)

Mar 07, 2025

Is Conduit Pharmaceuticals Inc. (CDT) the Best Micro Cap Stock to Buy Now? - Insider Monkey

Mar 07, 2025

Mar 06, 2025

Conduit Pharmaceuticals Gets Nasdaq Extension, Plans Capital Market Transfer -March 06, 2025 at 10:42 am EST - Marketscreener.com

Mar 06, 2025

Mar 06, 2025

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel - The Manila Times

Mar 06, 2025

Mar 06, 2025

Conduit Pharmaceuticals secures Nasdaq extension - Investing.com

Mar 06, 2025

Mar 06, 2025

Conduit Pharmaceuticals Secures Extension for Nasdaq Compliance Following Bid Price Regaining - Nasdaq

Mar 06, 2025

Mar 06, 2025

Conduit Pharmaceuticals secures Nasdaq extension By Investing.com - Investing.com Australia

Mar 06, 2025

Mar 04, 2025

Conduit Pharmaceuticals Inc (NASDAQ: CDT) Is Down -83.09% So Far This Year: What Will Happen Next? - Stocks Register

Mar 04, 2025

Mar 01, 2025

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Short Interest Update - Defense World

Mar 01, 2025

Feb 27, 2025

Taking a look at what insiders are doing to gauge the Conduit Pharmaceuticals Inc (CDT)’s direction - Knox Daily

Feb 27, 2025

Feb 20, 2025

Conduit Pharmaceuticals Advances Phase II AI Collaboration With Sarborg To Enhance Drug Development - Nasdaq

Feb 20, 2025

Feb 20, 2025

Conduit Progresses Phase II of its AI Initiative with Sarborg - The Manila Times

Feb 20, 2025

Feb 20, 2025

How Conduit's New AI System Could Revolutionize Drug Development Decision-Making - StockTitan

Feb 20, 2025

Feb 19, 2025

Conduit Pharmaceuticals acts to regain Nasdaq compliance By Investing.com - Investing.com South Africa

Feb 19, 2025

Feb 19, 2025

Conduit Pharmaceuticals acts to regain Nasdaq compliance - Investing.com India

Feb 19, 2025

Feb 19, 2025

Conduit Pharmaceuticals Files For Offering Of Up To $17.8 Million Of Shares Of Common StockSEC Filing - Marketscreener.com

Feb 19, 2025

Feb 18, 2025

Understanding the Risks of Investing in Conduit Pharmaceuticals Inc (CDT) - Knox Daily

Feb 18, 2025

Feb 18, 2025

Conduit Pharmaceuticals to execute 1-for-100 reverse stock split - MSN

Feb 18, 2025

Feb 17, 2025

Conduit Pharmaceuticals enacts reverse stock split to meet Nasdaq standards - MSN

Feb 17, 2025

Feb 13, 2025

Conduit Pharmaceuticals, Charles River Laboratories Partner to Evaluate Potential Lupus Treatment - Marketscreener.com

Feb 13, 2025

Feb 13, 2025

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model - The Manila Times

Feb 13, 2025

Feb 13, 2025

Major Lupus Breakthrough? Conduit Teams Up with Charles River for Game-Changing Treatment Study - StockTitan

Feb 13, 2025

Feb 13, 2025

Weekly TechBio News 🤹 - substack.com

Feb 13, 2025

Feb 12, 2025

Conduit Pharmaceuticals announces debt repayment and partial conversion of senior secured note - MSN

Feb 12, 2025

Feb 12, 2025

Small Cap Stocks To Watch NowFebruary 09th - MarketBeat

Feb 12, 2025

Feb 11, 2025

Promising Small Cap Stocks To Keep An Eye OnFebruary 07th - MarketBeat

Feb 11, 2025

Feb 11, 2025

Conduit Pharmaceuticals settles debt, converts senior note - MSN

Feb 11, 2025

Feb 11, 2025

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note - The Manila Times

Feb 11, 2025

Feb 11, 2025

Conduit Pharmaceuticals settles debt, converts senior note By Investing.com - Investing.com Australia

Feb 11, 2025

Feb 11, 2025

What is Conduit Pharmaceuticals Inc (CDT) Stock Return on Shareholders’ Capital? - SETE News

Feb 11, 2025

Feb 11, 2025

Conduit, MGO Global, and Cyclo Therapeutics: Penny Stocks to Watch This Week - PUNE.NEWS

Feb 11, 2025

Feb 11, 2025

3 Penny Stocks to Watch Now, 2/11/25 - TipRanks

Feb 11, 2025

Feb 10, 2025

Conduit Pharmaceuticals Inc [CDT] is -58.45% lower this YTD. Is it still time to buy? - The DBT News

Feb 10, 2025

Feb 10, 2025

CDT’s price-to-cash ratio: Is it a good investment at the moment? - US Post News

Feb 10, 2025

Feb 10, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 10, 2025

Feb 10, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Feb 10, 2025

Feb 08, 2025

Revolutionizing AI Investment: Why Conduit Pharmaceuticals is a Stock to Watch! - Jomfruland.net

Feb 08, 2025

Feb 08, 2025

Conduit Pharmaceuticals Inc. (CDT) Advances AI-Driven Drug Development to Phase II - Insider Monkey

Feb 08, 2025

Feb 07, 2025

Conduit Pharmaceuticals (NASDAQ:CDT) Stock Quotes, Forecast and News Summary - Benzinga

Feb 07, 2025

Feb 07, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Feb 07, 2025

Feb 07, 2025

Dow Dips 400 Points; US Adds Fewer Than Expected Jobs - Benzinga

Feb 07, 2025

Feb 07, 2025

CDT Stock Price and Chart — NASDAQ:CDT - TradingView

Feb 07, 2025

Feb 07, 2025

Stock market news: Conduit Pharmaceuticals +103.87%, Doximity +37.47% among top gainers as corporate earnings surpass investor estimates - Business Upturn

Feb 07, 2025

Feb 07, 2025

Stock market today: Conduit Pharmaceuticals +83.87%, Doximity +31.02% among top gainers as more companies release their quarterly earnings - Business Upturn

Feb 07, 2025

Feb 07, 2025

Stock Price Rise As Conduit (CDT) Marks Progress In Strategic Alliance - Stocks Telegraph

Feb 07, 2025

Feb 07, 2025

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development - The Manila Times

Feb 07, 2025

Feb 07, 2025

Conduit's AI-Powered Drug Development Takes Major Leap: Real-Time Trial Dashboard Unveiled - StockTitan

Feb 07, 2025

Feb 06, 2025

Conduit Pharmaceuticals Inc (CDT) requires closer examination - US Post News

Feb 06, 2025

Feb 05, 2025

Conduit Pharmaceuticals files to sell 5.9M shares of common stock for holders - MSN

Feb 05, 2025

Feb 05, 2025

Analysts review Conduit Pharmaceuticals Inc’s rating - Knox Daily

Feb 05, 2025

Feb 05, 2025

Closing Bell Recap: Conduit Pharmaceuticals Inc (CDT) Ends at 1.80, Reflecting a -18.18 Downturn - The Dwinnex

Feb 05, 2025